“The development of the novel drug, TE-1146, the CD38 specific antibody drug conjugate (ADC)” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan. The CDE case number is 114IDX05010.
“The development of the novel drug, TE-1146, the CD38 specific antibody drug conjugate (ADC)” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan. The CDE case number is 114IDX05010.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
